Leading In Product Development Means Planning For All Eventualities
Using Failure Investigation Data Earlier In Product Development
What is the cost of an adverse event, and the resulting safety action for a medical device that is already on the market? It is the kind of question that no company with products on the market wants to have to confront, but it is also one they know they should plan for, says the design consultancy and innovation organization NCS Lab srl.
You may also be interested in...
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.